Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of Ningyuyixing tablets for mild to moderate depression
ChiCTR-IIR-17012569Phase 3Completed
- Sponsor
- Xiyuan Hospital
- Start
- Sep 2008
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Shenyu Ningshen tablets in major depressive disorder (MDD) (3 arms), sponsored by Xiyuan Hospital. Primary endpoint: Hamilton Depression Scale. Started Sep 2008; status: completed.
02
Drugs
Shenyu Ningshen tablets
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR-IIR-17012569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17012569.